Correction: Targeting pro-dopaminergic agonism to attenuate depression in patients displaying genetic/epigenetic predisposition to hypodopaminergia

Kai-Uwe Lewandrowski, Kenneth Blum, Alexander P. L. Lewandrowski, Panayotis K. Thanos, Albert Pinhasov, Alireza Sharafshah, David Baron, Mark S. Gold, Catherine A. Dennen, Igor Elman, Aballa Bowirrat, Edward J. Modestino, Foojan Zeine, Nicole Jafari, Keerthy Sunder, Milan T. Makale, John Giordano, Marjorie C. Gondre-Lewis, Marco Lindenau, Brian S. Fuehrlein, Rajendra D. Badgaiyan, Chynna Levin, Sergio Luis Schmidt, Rossano Kepler Alvim Fiorelli

Open source

DOI
10.3389/fpubh.2025.1737084
Published
2025-11-17
Container
Frontiers in Public Health
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fpubh.2025.1737084,
  title = {Correction: Targeting pro-dopaminergic agonism to attenuate depression in patients displaying genetic/epigenetic predisposition to hypodopaminergia},
  author = {Kai-Uwe Lewandrowski and Kenneth Blum and Alexander P. L. Lewandrowski and Panayotis K. Thanos and Albert Pinhasov and Alireza Sharafshah and David Baron and Mark S. Gold and Catherine A. Dennen and Igor Elman and Aballa Bowirrat and Edward J. Modestino and Foojan Zeine and Nicole Jafari and Keerthy Sunder and Milan T. Makale and John Giordano and Marjorie C. Gondre-Lewis and Marco Lindenau and Brian S. Fuehrlein and Rajendra D. Badgaiyan and Chynna Levin and Sergio Luis Schmidt and Rossano Kepler Alvim Fiorelli},
  year = {2025},
  journal = {Frontiers in Public Health},
  doi = {10.3389/fpubh.2025.1737084},
  url = {https://doi.org/10.3389/fpubh.2025.1737084}
}

RIS

TY  - JOUR
TI  - Correction: Targeting pro-dopaminergic agonism to attenuate depression in patients displaying genetic/epigenetic predisposition to hypodopaminergia
AU  - Kai-Uwe Lewandrowski
AU  - Kenneth Blum
AU  - Alexander P. L. Lewandrowski
AU  - Panayotis K. Thanos
AU  - Albert Pinhasov
AU  - Alireza Sharafshah
AU  - David Baron
AU  - Mark S. Gold
AU  - Catherine A. Dennen
AU  - Igor Elman
AU  - Aballa Bowirrat
AU  - Edward J. Modestino
AU  - Foojan Zeine
AU  - Nicole Jafari
AU  - Keerthy Sunder
AU  - Milan T. Makale
AU  - John Giordano
AU  - Marjorie C. Gondre-Lewis
AU  - Marco Lindenau
AU  - Brian S. Fuehrlein
AU  - Rajendra D. Badgaiyan
AU  - Chynna Levin
AU  - Sergio Luis Schmidt
AU  - Rossano Kepler Alvim Fiorelli
PY  - 2025
JO  - Frontiers in Public Health
DO  - 10.3389/fpubh.2025.1737084
UR  - https://doi.org/10.3389/fpubh.2025.1737084
ER  - 

APA

Lewandrowski, K., Blum, K., Lewandrowski, A. P. L., Thanos, P. K., Pinhasov, A., Sharafshah, A., Baron, D., Gold, M. S., Dennen, C. A., Elman, I., Bowirrat, A., Modestino, E. J., Zeine, F., Jafari, N., Sunder, K., Makale, M. T., Giordano, J., Gondre-Lewis, M. C., Lindenau, M., Fuehrlein, B. S., Badgaiyan, R. D., Levin, C., Schmidt, S. L., & Fiorelli, R. K. A. (2025). Correction: Targeting pro-dopaminergic agonism to attenuate depression in patients displaying genetic/epigenetic predisposition to hypodopaminergia. Frontiers in Public Health. https://doi.org/10.3389/fpubh.2025.1737084

Source records